pleural empyema: The presence of pus in the thoracic cavity, between the visceral and parietal pleura. [database_cross_reference: NCIT:P378]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2784 |
4. Check minimum number of eventsNone |
2784 |
5. Include endpointsNone |
2784 |
6. Filter based on genotype QC (FinnGen only) |
2784 |
Control definitions (FinnGen only)
- Control exclude
- J10_LOWCHRON
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J40-J47
- Name in latin
- Emphysema pulmonale
Similar endpoints
↥List of similar endpoints to
Emphysema
based on the number of shared cases.
Similar with more cases:
- COPD
- Chronic lower respiratory diseases
- Excluding asthma or asthma-COPD overlap
- COPD differential diagnosis
- ILD differential diagnosis
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 25262 | 6005 | 18635 |
| Only index persons | 14435 | 4338 | 10097 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.44 | 0.17 | 0.52 |
| Only index persons | 0.32 | 0.16 | 0.39 |
| Median age at first event (years) | |||
| Whole population | 68.18 | 67.77 | 68.36 |
| Only index persons | 67.82 | 66.92 | 68.21 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2784 | 747 | 2037 |
| Unadjusted period prevalence (%) | 0.73 | 0.25 | 0.90 |
| Median age at first event (years) | 69.06 | 65.35 | 70.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2446
- Matched controls
- 24455
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J45.9
ICD-10 Finland
Asthma, unspecified
43.8
323.0
654
202
J43.2
ICD-10 Finland
Centrilobular emphysema
+∞
323.0
345
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
212.8
323.0
1325
135
R03AK06
ATC
salmeterol and fluticasone; inhalant
17.8
323.0
740
583
R03BB04
ATC
tiotropium bromide; inhalant
58.5
323.0
1080
326
J43.9
ICD-10 Finland
Emphysema, unspecified
6276.0
323.0
1649
8
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
468.6
323.0
462
12
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
443.6
323.0
673
21
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
323.0
932
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
225.2
323.0
544
31
R03AC02
ATC
salbutamol; inhalant
7.0
323.0
1617
5349
H02AB06
ATC
prednisolone; systemic
4.9
289.9
1531
6245
J45.1
ICD-10 Finland
Nonallergic asthma
243.9
277.5
281
13
J43.8
ICD-10 Finland
Other emphysema
2772.2
274.0
260
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.7
268.1
704
1220
R95
ICPC
Chron obstructive pulmonary disease
53.7
248.7
298
63
R03DA04
ATC
theophylline; systemic, rectal
18.8
244.6
388
242
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
13.1
234.7
435
396
R06.0
ICD-10 Finland
Dyspnoea
4.8
232.9
1001
3099
J96.1
ICD-10 Finland
Chronic respiratory failure
39.0
231.5
296
86
R03AK07
ATC
formoterol and budesonide; inhalant
7.3
228.7
614
1072
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
13.7
223.4
405
349
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
226.1
221.6
226
11
UGC12
NOMESCO Finland
Flexible bronchoscopy
8.0
216.3
541
843
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
52.7
205.4
247
52
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.0
205.0
1147
4430
R03AC12
ATC
salmeterol; inhalant
52.6
197.9
238
50
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
73.4
193.9
221
33
J45.0
ICD-10 Finland
Predominantly allergic asthma
135.2
187.3
199
16
R03BA02
ATC
budesonide; inhalant
6.5
163.4
466
850
R03BA01
ATC
beclometasone; inhalant
7.5
161.2
411
639
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
10.6
159.0
325
348
R03AC13
ATC
formoterol; inhalant
25.3
154.2
220
95
R03BA05
ATC
fluticasone; inhalant
5.6
147.7
477
1008
R03BB01
ATC
ipratropium bromide; inhalant
11.9
141.8
272
255
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
188.2
137.1
142
8
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.7
130.5
499
1258
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
128.8
1350
7406
J45
ICD-10 Finland
Asthma
13.9
124.4
221
174
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.9
123.2
377
735
J43.1
ICD-10 Finland
Panlobular emphysema
+∞
119.8
114
*
R02
ICPC
Shortness of breath/dyspnoea
4.6
117.6
456
1155
J47
ICD-10 Finland
Bronchiectasis
311.8
117.2
118
*
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
17.7
116.1
186
113
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
12.9
114.0
209
176
R96
ICPC
Asthma
13.0
112.8
206
172
R03DC03
ATC
montelukast; oral
5.6
105.7
337
684
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
11.6
105.2
203
190
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.1
103.7
303
552
R03AC03
ATC
terbutaline; inhalant
5.1
102.6
351
771
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.5
100.3
550
1871
XG410
NOMESCO Finland
Flow-volume spirometry
9.1
97.3
214
255
J45.8
ICD-10 Finland
Mixed asthma
201.8
94.0
97
5
J01MA14
ATC
moxifloxacin; systemic
4.7
92.9
347
833
GD1AD
NOMESCO Finland
Thorax CT examination
7.3
92.7
236
354
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
+∞
92.3
88
*
J46
ICD-10 Finland
Status asthmaticus
144.1
91.7
97
7
R03AK08
ATC
formoterol and beclometasone; inhalant
30.7
89.2
120
41
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
298.6
85.2
86
*
N07BA03
ATC
varenicline; oral
7.6
81.9
202
288
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
9.5
80.5
171
191
R03BA08
ATC
ciclesonide; inhalant
7.8
80.3
194
268
J01AA02
ATC
doxycycline; systemic
2.4
79.8
1859
13866
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
74.6
562
2334
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
20.0
72.8
111
58
C03CA01
ATC
furosemide; systemic
2.2
72.8
1028
5959
H02AB07
ATC
prednisone; oral
3.3
71.9
419
1459
R03AC18
ATC
indacaterol; inhalant
52.3
71.8
86
17
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
8.1
71.6
167
218
J43
ICD-10 Finland
Emphysema
+∞
70.1
67
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
67.7
1104
6757
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
20.4
67.5
102
52
I50.9
ICD-10 Finland
Heart failure, unspecified
2.6
64.8
560
2493
R04.2
ICD-10 Finland
Haemoptysis
6.1
64.1
184
322
J01MA12
ATC
levofloxacin; systemic
2.5
62.0
596
2809
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
30.2
61.0
82
28
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
60.7
338
1129
J01FA06
ATC
roxithromycin; oral
2.1
60.1
938
5549
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
208.3
59.3
61
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
44.2
59.1
73
17
TGC00
NOMESCO Finland
Bronchial lavation
7.9
59.0
140
187
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
5.5
58.9
185
361
R03AK11
ATC
formoterol and fluticasone; inhalant
26.6
57.6
80
31
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
13.9
54.4
95
71
49300
ICD-8 Finland
Asthma, bronchiale
+∞
54.4
52
*
49209
ICD-8 Finland
Emphysema, Unspecified
+∞
52.3
50
*
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
+∞
51.2
49
*
XG466
NOMESCO Finland
Sleep oxymetry
6.1
51.2
146
253
348
Kela drug reimbursment
Roflumilast
+∞
50.2
48
*
J43.0
ICD-10 Finland
MacLeod syndrome
+∞
50.2
48
*
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
14.7
47.7
81
57
Z72.0
ICD-10 Finland
Tobacco use
8.2
46.1
106
135
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.5
46.1
404
1780
A02BC02
ATC
pantoprazole; systemic
1.8
45.9
1481
11093
R03DX07
ATC
roflumilast; oral
+∞
43.9
42
*
R28
ICPC
Limited function/disability (R)
14.3
43.7
75
54
R03BB06
ATC
glycopyrronium bromide; inhalant
95.8
42.9
47
5
C07AB07
ATC
bisoprolol; oral
1.8
42.8
1277
9216
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
91.7
40.9
45
5
4920A
ICD-9 Finland
Emphysematous bleb
+∞
40.7
39
*
H02AB04
ATC
methylprednisolone; systemic
2.6
40.7
327
1366
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
6.7
39.9
104
160
R03BB07
ATC
umeclidinium bromide; inhalant
30.6
38.3
51
17
R03AC19
ATC
olodaterol; inhalant
135.4
37.8
40
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
36.4
735
4586
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
36.0
36.0
46
13
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
35.6
491
2652
J42
ICD-10 Finland
Unspecified chronic bronchitis
21.7
34.9
51
24
XG460
NOMESCO Finland
Short time oxymetry
6.3
34.7
94
153
R81
ICPC
Pneumonia
4.6
34.2
124
283
N02AX02
ATC
tramadol; systemic, rectal
1.7
34.0
1009
7082
R06.2
ICD-10 Finland
Wheezing
5.4
34.0
105
201
N05CF01
ATC
zopiclone; oral
1.8
33.8
826
5461
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.8
33.5
116
252
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
+∞
33.4
32
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
9.3
33.3
70
77
Z2446
NOMESCO Finland
Social worker
3.3
33.3
176
558
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
20.8
33.1
49
24
A07AA02
ATC
nystatin; oral
3.2
32.3
179
587
SPAT1059
SPAT
Spirometry at the office
4.0
31.8
133
348
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
5.1
31.6
102
206
4928X
ICD-9 Finland
Emphysema, Other emphysema[EMPHYSEMA ALIA DEFINITA]
+∞
31.3
30
*
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
+∞
31.3
30
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
31.3
560
3322
WX725
NOMESCO Finland
Noninvasive ventilation
3.8
30.8
135
368
I50.0
ICD-10 Finland
Congestive heart failure
2.4
30.8
284
1269
J93.9
ICD-10 Finland
Pneumothorax, unspecified
15.9
30.8
50
32
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
9.6
30.6
63
67
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
30.1
521
3046
J01CA04
ATC
amoxicillin; systemic
1.7
29.9
1651
13576
M05BA04
ATC
alendronic acid; oral
2.8
29.9
207
786
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.7
29.8
759
5037
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.6
29.6
138
396
J20
ICD-10 Finland
Acute bronchitis
2.7
29.0
213
839
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
28.4
709
4662
A02BC01
ATC
omeprazole; systemic
1.8
28.4
665
4288
XG405
NOMESCO Finland
Education on PEF monitoring
10.8
28.0
54
51
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
5.9
27.8
79
137
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
146.6
27.7
29
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
27.2
631
4048
Z94.2
ICD-10 Finland
Lung transplant status
41.7
26.8
33
8
N02AA05
ATC
oxycodone; systemic
1.9
26.1
420
2377
49201
ICD-8 Finland
Emphysema, Generale bronchitide non indicata
+∞
26.1
25
*
49202
ICD-8 Finland
Emphysema, Focale (bullosum)
+∞
26.1
25
*
WX892
NOMESCO Finland
Monitored bed care
2.5
25.6
209
871
J98.2
ICD-10 Finland
Interstitial emphysema
136.4
25.6
27
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
25.6
284
1382
R05
ICPC
Cough
1.9
25.4
420
2401
GDG10
NOMESCO Finland
Bilateral transplantation of lung
50.5
25.3
30
6
R4110
NOMESCO Finland
Physiotherapy
1.7
25.2
599
3860
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
6.5
25.1
66
104
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
+∞
25.0
24
*
WX721
NOMESCO Finland
Oxygen concentrator therapy
91.0
24.7
27
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.6
24.5
86
191
ZXE00
NOMESCO Finland
One hour or less
1.6
24.4
853
6102
ZXD05
NOMESCO Finland
Urgent procedure
1.6
24.1
720
4939
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.7
24.1
173
670
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
23.9
610
4002
N05BA04
ATC
oxazepam; oral
1.8
23.9
525
3295
A01AB09
ATC
miconazole; local oral
2.5
23.8
201
854
SPAT1257
SPAT
Teaching of medicine inhalation technique
4.3
23.7
90
216
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.5
23.6
85
194
R03DC01
ATC
zafirlukast; oral
14.0
23.6
40
29
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
23.5
227
1033
N06AX11
ATC
mirtazapine; oral
1.7
23.4
634
4226
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
23.3
182
739
XG474
NOMESCO Finland
Exhalation nntrogen oxide
9.1
23.3
49
55
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
23.1
257
1250
4928A
ICD-9 Finland
Emphysema, Other emphysema[EMPHYSEMA SINE BRONCHITIDE]
+∞
22.9
22
*
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
30.3
22.8
30
10
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
22.7
166
651
R03BB02
ATC
oxitropium bromide; inhalant
13.2
22.4
39
30
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
15.9
22.3
36
23
R06AE07
ATC
cetirizine; oral
1.6
22.1
722
5049
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
21.6
387
2262
J98.1
ICD-10 Finland
Pulmonary collapse
12.0
21.5
39
33
AN1
HP
Coronary angiography
1.9
21.5
360
2058
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
21.4
140
515
R29
ICPC
Respiratory symptom/complaint other
2.9
21.3
135
486
J01FA09
ATC
clarithromycin; systemic
1.7
21.1
547
3584
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
21.1
678
4709
J96.0
ICD-10 Finland
Acute respiratory failure
6.0
21.0
58
98
N03AX16
ATC
pregabalin; oral
1.7
20.9
487
3093
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
20.8
676
4704
R05CB01
ATC
acetylcysteine; inhalant, oral
5.4
20.6
62
117
J37.0
ICD-10 Finland
Chronic laryngitis
4.0
20.5
84
217
SPAT1058
SPAT
PEF monitoring instruction
2.6
20.2
155
626
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
48.4
20.2
24
5
Z3226
NOMESCO Finland
Physiotherapist
1.8
20.1
412
2512
K05.31
ICD-10 Finland
Periodontitis pronounced
2.1
20.0
231
1138
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
27.3
20.0
27
10
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
23.6
19.9
28
12
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
16.5
19.6
31
19
A02BA02
ATC
ranitidine; systemic
1.7
19.6
484
3123
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.1
19.5
111
371
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.9
19.4
124
449
A03
ICPC
Fever
2.0
19.2
253
1318
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
19.2
432
2709
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
11.4
19.0
35
31
A02BC03
ATC
lansoprazole; oral
1.6
18.9
640
4481
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
18.8
608
4207
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
+∞
18.8
18
*
L04AA06
ATC
mycophenolic acid; systemic
5.5
18.7
55
101
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
18.7
189
878
5120A
ICD-9 Finland
Pneumothorax, Spontaneous tension pneumothorax
21.9
18.2
26
12
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
5.3
18.1
55
105
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.8
18.0
119
441
C01DA14
ATC
isosorbide mononitrate; oral
1.6
18.0
523
3516
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
+∞
17.7
17
*
N06AB04
ATC
citalopram; systemic
1.7
17.6
428
2739
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
5.2
17.6
54
105
J01FF01
ATC
clindamycin; systemic
1.6
17.5
558
3840
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
17.4
654
4684
N05CD07
ATC
temazepam; oral
1.8
17.2
348
2105
C03DA01
ATC
spironolactone; oral
1.9
17.1
273
1529
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
6.1
16.9
46
77
A28
ICPC
Limited function/disability NOS
1.7
16.9
400
2539
49099
ICD-8 Finland
Bronchitis, unspecified
+∞
16.7
16
*
N06AA09
ATC
amitriptyline; systemic
2.0
16.6
211
1084
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
16.6
229
1216
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.6
16.4
121
478
N07BB01
ATC
disulfiram; oral
3.0
16.4
94
318
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
4.3
16.3
61
146
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
5.1
16.2
51
102
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
7.4
16.2
38
52
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
16.1
291
1699
J01FA15
ATC
telithromycin; oral
2.2
16.0
176
850
J96.9
ICD-10 Finland
Respiratory failure, unspecified
11.7
16.0
29
25
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
6.8
16.0
40
60
P17
ICPC
Tobacco abuse
6.6
15.8
40
61
Z3231
NOMESCO Finland
Registered nurse
1.5
15.8
599
4278
GDC00
NOMESCO Finland
Lobectomy of lung
7.3
15.7
37
51
GD2SN
NOMESCO Finland
Lung ventilation SPECT
8.8
15.7
33
38
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
+∞
15.6
15
*
J92.9
ICD-10 Finland
Pleural plaque without asbestos
4.8
15.6
52
111
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
15.6
435
2882
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
15.6
288
1692
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
15.5
477
3235
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
15.4
423
2787
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
15.3
293
1740
N06AB10
ATC
escitalopram; oral
1.7
15.3
309
1868
N03AX12
ATC
gabapentin; oral
1.8
15.1
291
1729
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
15.1
666
4911
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.1
15.0
82
270
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
5.4
15.0
44
82
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.3
14.9
76
237
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.1
14.9
81
265
R05
ICD-10 Finland
Cough
1.7
14.9
342
2147
N06AX16
ATC
venlafaxine; oral
2.0
14.8
203
1071
JN4BD
NOMESCO Finland
Extensive body CT
1.8
14.8
268
1563
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.6
14.6
109
432
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
14.6
787
6040
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
3.6
14.6
66
188
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
14.6
259
1502
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
14.6
772
5901
Z51.5
ICD-10 Finland
Palliative care
2.1
14.5
176
884
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
6.3
14.3
37
59
N05AA02
ATC
levomepromazine; systemic
2.6
14.2
105
417
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
3.3
14.1
72
226
N05BA01
ATC
diazepam; systemic, rectal
1.7
14.0
288
1749
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
7.3
14.0
33
46
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.4
13.9
118
505
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
13.9
536
3832
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
13.8
334
2123
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
53.6
13.8
16
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.8
13.8
57
151
R50.9
ICD-10 Finland
Fever, unspecified
1.7
13.8
302
1870
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
13.8
231
1315
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
13.7
866
6826
C01AA05
ATC
digoxin; systemic
1.7
13.7
274
1649
GD1UN
NOMESCO Finland
Lung circulation SPECT
8.6
13.7
29
34
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
10.5
13.7
26
25
SPAT1254
SPAT
Administration of medicine
1.7
13.6
316
1986
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.3
13.5
127
571
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
34.2
13.5
17
5
J01DA01
ATC
[U] cefalexin; systemic
1.4
13.5
1275
10780
WX730
NOMESCO Finland
Conventional respirator
3.8
13.4
56
150
A06AD11
ATC
lactulose; oral
1.6
13.3
390
2608
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
13.3
218
1230
SPAT1060
SPAT
Administration of oxygen
8.6
13.2
28
33
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
6.9
13.1
32
47
B01AC04
ATC
clopidogrel; oral
1.5
13.1
431
2967
SPAT1263
SPAT
Sampling
1.4
13.0
819
6439
WX882
NOMESCO Finland
High dependency care
3.0
13.0
75
256
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
8.8
13.0
27
31
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
12.8
125
574
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
6.0
12.7
34
57
F10.24
ICD-10 Finland
Alcohol depence active use
5.4
12.7
37
69
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
12.7
510
3669
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
12.6
503
3611
GX2D5
NOMESCO Finland
Sleep oximetry
15.5
12.6
20
13
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
+∞
12.5
12
*
GDB00
NOMESCO Finland
Resection of bullae of lung
+∞
12.5
12
*
GX1K5
NOMESCO Finland
Diffusion capacity
24.4
12.5
17
7
WX722
NOMESCO Finland
PEEP
2.3
12.4
112
496
N05AH04
ATC
quetiapine; oral
1.7
12.4
271
1676
R78
ICPC
Acute bronchitis/bronchiolitis
3.6
12.3
54
151
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.9
12.3
50
131
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
8.5
12.3
26
31
GDB01
NOMESCO Finland
Thoracoscopic resection of bullae of lung
37.7
12.2
15
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
12.1
598
4475
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
12.1
195
1093
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
12.1
278
1742
P01AB01
ATC
metronidazole; oral, rectal
1.4
12.1
687
5285
A02BC05
ATC
esomeprazole; systemic
1.4
12.1
764
5993
J41.0
ICD-10 Finland
Simple chronic bronchitis
18.1
12.0
18
10
127
Kela drug reimbursment
Transplant complication
4.4
12.0
42
96
J01DB01
ATC
cefalexin; oral
1.4
11.9
1643
14635
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.3
11.9
108
479
N02BE01
ATC
paracetamol; systemic, rectal
1.4
11.9
1802
16314
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
11.9
141
703
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.4
11.8
96
403
TGD00
NOMESCO Finland
Needle biopsy of lung
7.4
11.7
27
37
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
23.0
11.6
16
7
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
11.5
340
2274
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
11.4
354
4922
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
11.4
180
1005
S22.3
ICD-10 Finland
Fracture of rib
2.0
11.3
144
740
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
11.3
631
4828
GX2C5
NOMESCO Finland
Short-lasting oximetry
35.2
11.3
14
*
R63.4
ICD-10 Finland
Abnormal weight loss
2.6
11.2
82
325
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.4
11.2
92
389
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
11.1
111
516
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
25.1
11.1
15
6
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
25.1
11.1
15
6
R03BB05
ATC
aclidinium bromide; inhalant
25.1
11.1
15
6
G47.3
ICD-10 Finland
Sleep apnoea
1.5
11.1
377
2604
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.2
11.1
115
543
J86.9
ICD-10 Finland
Pyothorax without fistula
5.1
11.1
34
68
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
3.8
11.0
45
119
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
4.3
11.0
40
95
F32.1
ICD-10 Finland
Moderate depressive episode
3.0
11.0
63
215
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
11.0
184
1048
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
3.6
10.9
48
136
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
10.8
281
1819
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
10.8
116
558
I50
ICD-10 Finland
Heart failure
2.4
10.7
86
359
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.0
10.7
61
206
Z2221
NOMESCO Finland
Medical doctor
1.4
10.5
526
3936
WZC30
NOMESCO Finland
Teaching
1.6
10.5
248
1567
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.8
10.4
177
1012
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
10.4
198
1175
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.0
10.3
59
200
N06AA12
ATC
doxepin; systemic
2.1
10.3
114
552
R52.9
ICD-10 Finland
Pain, unspecified
1.9
10.3
152
828
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
3.0
10.3
59
202
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
9.6
10.2
20
21
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.2
10.2
52
165
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.8
10.2
42
113
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.7
10.2
66
246
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
10.1
130
674
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
10.0
98
453
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.3
9.9
92
413
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
4.8
9.9
32
68
WW200
NOMESCO Finland
Immunization
2.9
9.9
58
202
N05AF03
ATC
chlorprothixene; systemic
3.1
9.9
52
169
284
Kela drug reimbursment
Nintedanib and pirfenidone
6.7
9.9
24
36
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
16.8
9.9
15
9
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
16.8
9.9
15
9
R05FB02
ATC
cough suppressants and expectorants
1.4
9.8
760
6119
N05BA12
ATC
alprazolam; oral
1.7
9.7
183
1080
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
55.2
9.6
11
*
N06AX21
ATC
duloxetine; oral
1.8
9.6
163
928
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.7
9.6
65
247
J01DA06
ATC
[U] cefuroxime; systemic
1.6
9.6
261
1708
L28
ICPC
Limited function/disability (L)
1.5
9.6
330
2282
AA1AD
NOMESCO Finland
CT of head and brain
1.4
9.5
522
3965
R03DA05
ATC
aminophylline; systemic, rectal
5.7
9.5
26
46
E0000UV
ATC
NA
1.4
9.5
689
5487
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.8
9.5
156
881
RS221
NOMESCO Finland
NA
4.1
9.4
35
86
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
9.4
103
499
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
+∞
9.4
9
*
49101
ICD-8 Finland
Chronic bronchitis, Nonpurulenta (simplex)
+∞
9.4
9
*
3A006
NOMESCO Finland
NA
+∞
9.4
9
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
9.4
261
1717
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
9.4
299
2033
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
3.9
9.3
37
97
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.1
9.3
48
155
A01AB04
ATC
amphotericin B; local oral
2.2
9.3
97
460
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.2
9.2
47
150
L04AD01
ATC
ciclosporin; systemic
3.5
9.1
41
119
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
9.1
211
1324
C09AA05
ATC
ramipril; oral
1.4
9.1
599
4689
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
9.1
91
424
R07.3
ICD-10 Finland
Other chest pain
1.7
9.1
184
1110
R01AD09
ATC
mometasone; nasal
1.4
9.1
653
5185
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.1
9.1
94
447
J01FA10
ATC
azithromycin; systemic
1.3
9.1
872
7237
51299
ICD-8 Finland
Spontaneous pneumothorax
8.3
9.1
19
23
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
2.5
9.0
66
264
M05BA07
ATC
risedronic acid; oral
2.7
9.0
59
222
B01AF02
ATC
apixaban; oral
1.6
9.0
230
1478
R99
ICPC
Respiratory disease other
3.4
9.0
41
121
R79
ICPC
Chronic bronchitis
24.1
8.9
12
5
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.2
8.9
44
138
ZX108
NOMESCO Finland
Inhalation
5.5
8.9
25
46
R13
ICD-10 Finland
Dysphagia
1.9
8.9
135
746
30041
ICD-8 Finland
Neuroses, Depressiva
3.5
8.9
40
117
R51.80
ICD-10 Finland
Headache
1.7
8.8
195
1205
Z57.2
ICD-10 Finland
Occupational exposure to dust
8.6
8.8
18
21
R24
ICPC
Haemoptysis
5.9
8.7
23
39
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.8
8.7
137
762
I25.2
ICD-10 Finland
Old myocardial infarction
1.6
8.7
224
1443
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
8.7
135
748
WX250
NOMESCO Finland
Intercostal blockade
14.1
8.7
14
10
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.7
8.6
55
203
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
8.6
576
4514
M54.5
ICD-10 Finland
Low back pain
1.4
8.5
520
4012
B01AA03
ATC
warfarin; systemic
1.4
8.5
559
4369
XQ800
NOMESCO Finland
Prick test
2.3
8.5
74
323
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.2
8.5
42
132
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.4
8.5
66
274
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.0
8.5
105
536
F32
ICD-10 Finland
Depressive episode
2.4
8.4
66
275
R84
ICPC
Malignant neoplasm bronchus/lung
7.4
8.4
19
26
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
8.4
496
3807
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
4.5
8.3
28
63
4919X
ICD-9 Finland
Chronic bronchitis, Unspecified chronic bronchitis
+∞
8.3
8
*
4900A
ICD-9 Finland
Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]
+∞
8.3
8
*
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
+∞
8.3
8
*
J01GB01
ATC
tobramycin; inhalant, parenteral
+∞
8.3
8
*
4939A
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]
+∞
8.3
8
*
R01AD12
ATC
fluticasone furoate; nasal
1.4
8.3
365
2653
SPAT1260
SPAT
Consultation of another employee
1.5
8.3
327
2324
J01DA08
ATC
[U] cefaclor; oral
1.9
8.3
126
695
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
8.3
79
363
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
10.8
8.3
15
14
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.3
8.3
71
311
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
8.3
139
795
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
8.2
611
4864
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
7.1
8.2
19
27
XJC10
NOMESCO Finland
Oesophageal pH monitoring
7.1
8.2
19
27
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
8.2
576
4545
C08DA01
ATC
verapamil; systemic
2.1
8.2
90
440
A02BA03
ATC
famotidine; systemic
2.0
8.2
97
490
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
6.0
8.1
21
35
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
8.1
679
5500
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.7
8.1
33
89
R53
ICD-10 Finland
Malaise and fatigue
1.4
8.1
396
2934
P01BA02
ATC
hydroxychloroquine; oral
1.8
8.1
137
783
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
17.2
8.1
12
7
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
17.2
8.1
12
7
R04.0
ICD-10 Finland
Epistaxis
1.7
8.0
168
1025
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
8.0
156
932
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
4.1
8.0
29
71
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
8.0
147
866
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
7.2
8.0
18
25
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
13.1
7.9
13
10
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
13.1
7.9
13
10
RK250
NOMESCO Finland
NA
7.8
7.9
17
22
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
2.6
7.8
54
209
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
3.9
7.8
30
77
N02AA01
ATC
morphine; systemic, rectal
2.7
7.8
50
185
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
3.7
7.8
32
87
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
7.8
135
779
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
4.3
7.8
27
63
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
7.8
311
2219
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
7.8
80
381
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
7.8
197
1267
SPAT1104
SPAT
Monitoring of emergency patient
1.7
7.7
143
841
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
15.1
7.7
12
8
P76
ICPC
Depressive disorder
2.3
7.7
69
308
J12.8
ICD-10 Finland
Other viral pneumonia
5.3
7.7
22
42
L01CA04
ATC
vinorelbine; systemic
4.6
7.7
25
55
PDH54
NOMESCO Finland
Bypass from aorta to bilateral femoral arteries
7.4
7.7
17
23
N05AA01
ATC
chlorpromazine; systemic, rectal
3.5
7.7
33
94
F51.0
ICD-10 Finland
Nonorganic insomnia
1.7
7.6
166
1026
UJF32
NOMESCO Finland
Coloscopy
1.4
7.6
515
4033
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
18.4
7.6
11
6
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
7.6
109
592
EBA00
NOMESCO Finland
Extraction of tooth
1.3
7.6
560
4445
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.0
7.6
88
441
RS230
NOMESCO Finland
NA
6.7
7.6
18
27
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
3.6
7.5
32
90
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.8
7.5
125
709
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.0
7.5
92
470
A02BA04
ATC
nizatidine; systemic
1.6
7.5
171
1068
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
5.4
7.5
21
39
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.5
368
2728
PD5BD
NOMESCO Finland
Extensive CT of aorta
2.6
7.5
52
203
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.8
7.5
125
715
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
3.5
7.5
33
96
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
7.5
121
684
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.4
7.4
25
57
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
3.2
7.4
37
118
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
3.2
7.4
36
113
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
7.4
201
1318
EBA30
NOMESCO Finland
Excision of root of tooth
1.8
7.4
115
643
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
7.4
109
598
D07AC01
ATC
betamethasone; topical
1.3
7.3
643
5233
R01
ICPC
Pain respiratory system
3.8
7.3
29
77
G44.2
ICD-10 Finland
Tension-type headache
1.6
7.3
169
1058
ZX120
NOMESCO Finland
Intravenous
1.6
7.3
183
1172
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
8.4
7.3
15
18
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
3.0
7.3
39
131
F34.1
ICD-10 Finland
Dysthymia
2.6
7.3
49
190
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.9
7.2
28
73
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.6
7.2
165
1032
RK110
NOMESCO Finland
NA
4.6
7.2
23
50
N05AC02
ATC
thioridazine; oral
3.0
7.2
38
127
SPAT1057
SPAT
Peak expiratory flow measurement
3.3
7.2
34
105
J93
ICD-10 Finland
Pneumothorax
30.1
7.1
9
*
GAC40
NOMESCO Finland
Pleurodesis with decortication
30.1
7.1
9
*
GAC47
NOMESCO Finland
Endoscopic partial decortication of pleura
20.1
7.1
10
5
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
7.1
146
889
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.0
7.1
82
410
WX402
NOMESCO Finland
General anaesthesia
1.5
7.1
264
1857
M79.6
ICD-10 Finland
Pain in limb
1.3
7.1
578
4654
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.7
7.1
155
959
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
5.6
7.1
19
34
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.5
7.1
50
199
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.8
7.0
28
75
H05AA02
ATC
teriparatide; parenteral
8.8
7.0
14
16
N06AX12
ATC
bupropion; oral
2.3
7.0
64
287
D19
ICPC
Teeth/gum symptom/complaint
0.7
7.0
204
2890
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
3.0
7.0
37
124
E000001
ATC
NA
1.4
7.0
340
2518
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
4.0
7.0
26
66
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
6.9
122
710
S72.0
ICD-10 Finland
Fracture of neck of femur
1.9
6.9
103
565
A04
ICPC
Weakness/tiredness general
1.5
6.9
228
1563
J18
ICD-10 Finland
Pneumonia, organism unspecified
4.2
6.9
24
57
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
4.6
6.9
22
48
A02BX05
ATC
bismuth subcitrate; oral
2.8
6.9
42
154
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
3.5
6.9
30
87
W19
ICD-10 Finland
Unspecified fall
1.6
6.9
180
1167
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.6
6.9
29
82
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.0
6.9
36
120
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.4
6.8
52
215
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
4.8
6.8
21
44
L57.0
ICD-10 Finland
Actinic keratosis
0.6
6.8
97
1599
318
Kela drug reimbursment
Teriparatide
8.3
6.8
14
17
ZXA10
NOMESCO Finland
Bilateral
1.4
6.8
347
2589
E88.9
ICD-10 Finland
Metabolic disorder, unspecified
40.1
6.8
8
*
J41.8
ICD-10 Finland
Mixed simple and mucopurulent chronic bronchitis
40.1
6.8
8
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.8
6.8
41
150
356
Kela drug reimbursment
Nintedanib and pirfenidone
5.7
6.7
18
32
R50
ICPC
Respiratory, Medication/prescr/renewal
16.7
6.7
10
6
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
2.9
6.7
39
137
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
2.2
6.7
66
310
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
6.7
262
1858
ZPB22
NOMESCO Finland
Autograft of vein
4.3
6.7
23
54
J15.8
ICD-10 Finland
Other bacterial pneumonia
4.3
6.7
23
54
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
6.7
324
2397
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
6.4
6.6
16
25
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.9
6.6
93
502
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
6.6
101
562
H02AB09
ATC
hydrocortisone; systemic
2.9
6.6
38
132
N06AX03
ATC
mianserin; oral
1.9
6.6
91
489
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
3.4
6.6
29
85
WX872
NOMESCO Finland
Intensive care
1.8
6.6
106
599
N06AB03
ATC
fluoxetine; oral
1.6
6.6
186
1230
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
4.0
6.6
24
60
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.8
6.5
111
641
R52.2
ICD-10 Finland
Other chronic pain
2.4
6.5
53
228
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.7
6.5
133
808
N06AB06
ATC
sertraline; oral
1.7
6.5
140
866
R60.0
ICD-10 Finland
Localized oedema
1.5
6.5
207
1407
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
6.5
408
3156
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
6.5
379
2896
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.0
6.5
75
377
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.6
6.5
44
173
SPAT1255
SPAT
Intravenous administration of medicine
1.7
6.5
123
735
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.9
6.4
83
433
M05BX04
ATC
denosumab; parenteral
1.9
6.4
85
451
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
6.4
279
2025
DQA10
NOMESCO Finland
Biopsy of larynx
4.9
6.3
19
39
SPAT1301
SPAT
No procedures
1.3
6.3
601
4929
5BA08
NOMESCO Finland
NA
6.6
6.3
15
23
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
6.3
82
429
L04AX01
ATC
azathioprine; systemic
2.0
6.3
74
375
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
5.5
6.3
17
31
XX4BW
NOMESCO Finland
NA
9.3
6.3
12
13
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.8
6.3
37
133
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.5
6.3
61
1110
5AB14
NOMESCO Finland
NA
18.0
6.3
9
5
4939B
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]
+∞
6.2
6
*
49200
ICD-8 Finland
NA
+∞
6.2
6
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
2.9
6.2
34
117
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.3
6.2
21
49
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.0
6.2
69
342
A01AB10
ATC
natamycin; local oral
2.2
6.2
56
252
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.7
6.2
122
737
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
0.5
6.2
49
945
T74.1
ICD-10 Finland
Physical abuse
3.9
6.2
23
59
UDQ22
NOMESCO Finland
Microlaryngoscopy
3.6
6.2
25
69
ZXA05
NOMESCO Finland
Left side
1.3
6.2
509
4095
S01ED51
ATC
timolol, combinations; ophthalmic
0.6
6.1
69
1206
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
6.1
271
1972
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.9
6.1
79
414
OAA67
SPAT
NA
0.3
6.1
13
420
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.7
6.1
131
808
E66.00
ICD-10 Finland
Metabolic syndrome
1.9
6.1
83
445
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.5
6.1
26
75
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
6.1
142
898
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.5
6.0
43
171
J93.8
ICD-10 Finland
Other pneumothorax
4.9
6.0
18
37
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
6.0
148
947
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
6.7
6.0
14
21
R85
ICPC
Malignant neopl respiratory other
10.0
6.0
11
11
ZY010
NOMESCO Finland
Hospital outpatient
2.1
6.0
60
283
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
6.0
115
686
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.8
6.0
92
514
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
6.0
160
1043
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023419) Bacteria identified in Sputum by Culture
254
150
18.53
311.33
3.4
1.6
—
—
—
0
0
(4010399)
505
939
6.35
267.61
1.8
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
613
1436
5.19
251.25
4.7
4.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
814
2573
4.06
224.52
8.3
7.1
mmol/l
1.5
0.8
5.08
663
1979
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
811
2573
4.04
222.29
8.3
7.1
kpa
5.1
5.0
2.93
771
2449
(3027801) Oxygen [Partial pressure] in Arterial blood
810
2572
4.03
221.69
8.3
7.1
kpa
9.4
12.3
67.06
771
2450
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
384
661
6.58
218.23
3.9
2.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
339
581
6.50
192.80
1.4
1.1
u/ml
218.9
209.5
0.09
313
521
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
473
1158
4.72
180.40
8.7
9.3
mmol/l
24.8
24.0
5.09
436
1075
(3000492) Spirometry study
471
1153
4.71
179.62
2.1
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
208
226
9.86
174.95
1.1
1.1
g/l
1.5
1.6
0.58
192
202
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
726
2476
3.61
174.45
2.7
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
722
2488
3.57
170.33
2.7
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
689
2371
3.53
162.11
8.5
7.4
%
92.5
95.6
19.63
658
2274
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
172
160
11.39
161.29
4.4
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
892
3651
3.12
156.98
2.8
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1318
6785
2.79
150.24
7.5
5.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
188
221
9.05
148.62
1.2
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1661
9933
2.67
135.59
8.7
5.7
e9/l
0.2
0.2
0.82
1463
8525
(3022096) Basophils/100 leukocytes in Blood
1531
8831
2.63
134.17
8.4
5.9
%
0.6
0.7
4.17
1471
8126
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
250
456
5.92
132.30
2.2
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1620
9670
2.61
131.13
8.3
5.5
e9/l
0.0
0.0
5.19
1412
8171
(3019069) Monocytes/100 leukocytes in Blood
1556
9126
2.60
130.45
8.9
6.2
%
8.8
9.0
2.31
1493
8423
(3001604) Monocytes [#/volume] in Blood
1611
9607
2.61
130.40
8.4
5.5
e9/l
0.7
0.6
29.82
1403
8112
(3006504) Eosinophils/100 leukocytes in Blood
1551
9091
2.59
130.07
8.6
5.8
%
2.5
2.9
6.67
1487
8356
(3023368) Bacteria identified in Blood by Culture
1238
6555
2.60
128.02
6.1
4.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1565
9303
2.56
125.98
8.7
6.0
%
23.1
26.6
31.10
1500
8520
(3019198) Lymphocytes [#/volume] in Blood
1625
9841
2.56
125.56
8.4
5.6
e9/l
1.8
1.9
0.52
1436
8453
(3018010) Neutrophils/100 leukocytes in Blood
1533
9156
2.50
120.17
8.5
5.7
%
61.8
58.1
25.19
1470
8431
(3042631) Mycobacterium sp identified in Specimen
178
253
7.45
119.75
3.3
2.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
572
2193
3.02
108.48
9.6
7.7
g/l
128.3
120.3
13.70
544
2111
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
409
1283
3.56
108.04
9.9
7.0
mmol/l
25.6
24.4
5.59
403
1270
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
219
463
5.05
97.92
2.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
225
493
4.88
96.41
2.2
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
212
449
5.03
94.54
2.3
2.1
g/l
131.5
128.8
0.53
108
339
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
178
324
5.80
93.93
2.3
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1698
11407
2.25
91.15
11.8
8.8
e9/l
5.1
4.2
32.93
1505
9820
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
201
423
5.04
90.24
1.7
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
201
423
5.04
90.24
1.7
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
69
35
20.19
89.77
1.5
1.1
u/ml
1.9
0.1
—
47
10
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
798
3956
2.43
88.69
2.2
1.7
mg/l
1.4
1.6
0.68
656
3075
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
92
84
11.29
86.98
4.4
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1201
7175
2.18
84.59
3.9
3.0
ng/l
1851.3
1891.5
0.11
1072
6183
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
376
1329
3.11
80.71
5.0
3.3
mmol/l
2.2
1.5
2.46
294
932
(1616796) Gas panel - Central venous blood
203
473
4.55
80.44
5.6
3.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
149
267
5.84
79.81
2.3
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
174
361
5.07
79.30
2.3
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
387
1406
3.04
79.11
5.2
3.4
kpa
5.3
5.1
4.39
375
1278
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
113
153
7.65
79.09
2.7
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1490
9846
2.10
78.86
8.8
6.0
mmol/l
1.2
1.2
4.66
1359
8820
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
155
293
5.54
78.41
2.1
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
382
1385
3.04
78.33
5.1
3.4
ph
7.4
7.4
0.06
66
159
(3014111) Lactate [Moles/volume] in Serum or Plasma
484
2001
2.72
77.71
8.9
6.6
mmol/l
1.4
1.4
0.11
466
1917
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
359
1264
3.11
77.43
11.5
9.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
136
231
6.14
76.95
2.6
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
198
483
4.34
73.90
4.1
2.6
kpa
7.1
8.0
10.33
190
444
(3000991) Gas panel - Venous blood
457
1911
2.66
71.31
10.6
7.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
1056
6341
2.07
70.04
4.7
4.1
ph
7.4
7.4
2.05
235
1217
(3027315) Oxygen [Partial pressure] in Blood
195
492
4.19
69.55
8.1
4.4
kpa
7.7
8.4
7.31
190
478
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1565
10834
2.01
69.41
9.1
6.8
mmol/l
1.2
1.2
4.93
1297
9042
(3014576) Chloride [Moles/volume] in Serum or Plasma
601
2901
2.37
68.76
10.5
6.6
mmol/l
103.7
104.6
4.21
569
2828
(3013290) Carbon dioxide [Partial pressure] in Blood
193
489
4.17
68.44
8.2
4.3
kpa
5.1
4.9
1.91
188
476
(3012501) Base excess in Blood by calculation
193
489
4.17
68.44
8.2
4.3
mmol/l
3.0
2.5
1.13
142
311
(3010421) pH of Blood
210
571
3.90
67.55
8.0
4.0
ph
7.4
7.4
0.43
188
477
(3015235) Bicarbonate [Moles/volume] in Capillary blood
206
554
3.94
67.30
4.6
2.7
mmol/l
25.4
24.4
2.27
190
475
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
145
300
5.04
66.19
1.8
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
482
2146
2.51
65.68
4.9
3.7
mmol/l
2.7
1.6
5.73
397
1684
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
135
265
5.30
65.42
1.8
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
368
1448
2.78
64.33
9.5
6.7
mmol/l
24.5
24.2
0.63
341
1345
(3021447) Carbon dioxide [Partial pressure] in Venous blood
478
2150
2.48
63.57
4.9
3.6
kpa
6.1
5.7
7.43
464
2073
(3012095) Magnesium [Moles/volume] in Serum or Plasma
669
3484
2.21
63.27
5.6
3.2
mmol/l
0.8
0.8
2.56
632
3245
(44806118)
116
207
5.80
62.31
2.5
1.4
—
—
—
0
0
(44790049)
116
207
5.80
62.31
2.5
1.4
—
—
—
0
0
(44790047)
116
207
5.80
62.31
2.5
1.4
—
—
—
0
0
(44790048)
116
207
5.80
62.31
2.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
166
403
4.32
62.22
3.9
2.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1561
11082
1.93
61.11
8.1
6.3
umol/l
11.4
12.8
4.26
1489
10497
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
289
1062
2.92
57.14
4.6
4.0
mmol/l
24.8
23.7
4.68
264
936
(3032080) INR in Blood by Coagulation assay
1377
9607
1.86
54.55
13.2
11.0
inr
1.3
1.4
1.14
411
2610
(40767503) Oxygen content in Capillary blood by calculation
170
471
3.78
53.07
3.7
2.3
%
15.3
16.2
1.47
93
231
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
759
4404
1.99
52.44
5.9
3.8
ng/l
798.6
727.9
0.08
687
3756
(3005719) IgG [Mass/volume] in Serum or Plasma
330
1371
2.60
51.28
3.0
2.8
g/l
10.3
10.8
1.23
313
1236
(3037522) Nuclear Ab [Titer] in Serum
450
2158
2.29
50.95
1.4
1.3
titre
451.6
460.1
0.03
94
473
(3024561) Albumin [Mass/volume] in Serum or Plasma
1339
9428
1.81
49.94
5.9
4.9
g/l
33.2
34.8
18.52
1251
8679
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
952
6185
1.82
45.21
4.3
3.2
u/l
35.2
40.3
0.53
893
5856
(3042936) Bacteria identified in Isolate by Culture
553
3005
2.05
45.07
2.4
2.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
37
22
17.03
44.50
3.2
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
309
1329
2.49
44.40
2.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
257
1014
2.69
44.09
5.6
3.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
843
5322
1.84
43.68
6.2
3.9
%
84.7
83.5
0.67
825
5198
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
136
370
3.81
43.53
3.3
3.8
%
60.3
58.2
1.00
136
370
(3037692) Legionella sp identified in Specimen by Organism specific culture
54
62
8.86
43.19
2.5
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
143
405
3.67
43.17
1.5
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
266
1079
2.62
43.15
2.0
2.0
g/l
1.2
1.4
1.00
243
964
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
423
2109
2.19
43.07
3.9
2.9
ng/l
223.5
253.2
0.61
391
1925
(3030905) Polymorphonuclear cells [#/volume] in Blood
132
356
3.84
42.78
3.1
3.4
e9/l
5.0
4.3
1.92
132
356
(3024354) Oxygen [Partial pressure] in Venous blood
369
1774
2.24
40.99
4.1
3.0
kpa
4.2
4.5
2.60
353
1708
(3000494) Fungus identified in Specimen by Culture
428
2185
2.13
40.89
2.5
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
88
180
5.02
40.65
1.9
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1647
12746
1.72
40.56
8.7
4.7
mmol/l
6.7
6.9
5.70
1586
12001
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
315
1428
2.36
40.14
2.4
1.6
—
—
—
0
0
(3019977) pH of Arterial blood
71
124
5.85
38.98
2.6
2.5
ph
7.4
7.4
0.10
32
37
(3021589) Normoblasts [#/volume] in Blood
1205
8666
1.69
38.25
15.5
10.0
e9/l
0.0
0.0
0.50
967
7040
(46235355) HIV 1 and 2 tests - Meaningful Use set
395
2003
2.13
38.24
1.5
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1005
6900
1.71
37.81
4.9
3.4
e6/l
145.8
115.6
0.13
797
5418
(40760892) CBC W Ordered Manual Differential panel - Blood
650
3932
1.85
37.79
7.1
4.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
964
6562
1.72
37.30
2.9
2.5
u/l
54.7
59.3
3.04
900
6032
(3018677) aPTT in Platelet poor plasma by Coagulation assay
605
3595
1.87
37.15
2.2
2.0
s
30.6
30.1
1.19
587
3481
(3047181) Lactate [Moles/volume] in Blood
189
695
2.84
36.99
7.4
6.4
mmol/l
1.3
1.4
0.65
168
613
(4015189)
38
33
11.66
36.96
2.2
1.4
—
—
—
0
0
(3020891) Body temperature
223
902
2.60
36.24
6.1
4.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
773
4982
1.76
36.13
8.6
6.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
919
6240
1.71
35.50
4.7
3.3
e6/l
0.6
0.5
0.64
721
4809
(3020779) Urea [Moles/volume] in Serum or Plasma
409
2164
2.04
35.17
9.2
7.1
mmol/l
10.6
11.3
1.09
390
2044
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
66
119
5.66
35.06
2.0
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
886
5988
1.70
34.65
4.7
3.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
240
1032
2.45
34.25
2.1
1.9
ug/l
1.2
2.8
1.72
217
901
(3018095) Leukocytes [#/volume] in Urine
1085
7760
1.65
34.01
5.6
3.9
e6/l
74.7
117.1
1.34
830
5761
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
141
5.14
33.94
1.9
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
340
1702
2.14
33.82
4.6
4.2
%
0.9
1.0
0.08
136
535
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
65
121
5.48
33.37
2.0
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
712
4570
1.75
33.34
3.5
2.8
mosm/kgh2o
537.4
567.5
3.79
627
3889
(3025159) Blasts/100 leukocytes in Blood
305
1486
2.18
32.45
4.6
4.2
%
0.0
0.2
2.14
109
401
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
316
1577
2.13
31.59
1.7
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1170
8667
1.60
30.96
5.9
3.8
ng/l
117.4
85.0
0.16
937
6670
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
150
540
2.88
30.49
2.5
2.1
%
88.9
87.3
0.38
145
520
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
579
3595
1.77
30.03
4.4
3.2
e6/l
2.4
1.4
2.36
318
2065
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1925
16132
1.63
29.52
10.9
7.5
u/l
83.2
81.5
0.70
1841
15063
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
181
734
2.57
29.18
1.6
1.8
u/l
38.8
38.0
0.15
158
612
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
218
966
2.36
29.01
6.3
5.3
%
2.0
1.6
4.63
202
903
(3021440) Promyelocytes/100 leukocytes in Blood
312
1609
2.06
28.48
4.7
4.2
%
0.2
0.1
0.35
126
489
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
348
1873
1.98
28.18
3.0
2.4
u/l
32.1
39.1
1.30
306
1589
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
140
509
2.84
27.94
2.6
2.2
%
203.4
202.0
0.07
135
484
(3002179) Metamyelocytes/100 leukocytes in Blood
300
1536
2.07
27.90
4.4
4.0
%
0.5
0.6
0.42
96
371
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
369
2039
1.93
27.64
2.1
2.1
g/l
0.2
0.2
0.21
336
1888
(3000850) Epithelial cells [#/volume] in Urine
721
4850
1.66
27.54
3.5
2.6
e6/l
4.8
4.1
0.84
645
4264
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
410
2349
1.87
27.49
2.6
2.7
umol/l
8.2
10.2
1.15
355
2085
(3015171) Extractable nuclear Ab [Units/volume] in Serum
149
568
2.71
27.18
1.2
1.2
u/ml
0.4
0.8
0.49
16
51
(3003458) Phosphate [Moles/volume] in Serum or Plasma
494
3006
1.78
27.18
6.5
5.8
mmol/l
1.1
1.0
0.67
460
2768
(3022948) Iron [Moles/volume] in Serum or Plasma
564
3565
1.73
27.16
2.7
2.5
umol/l
11.2
12.7
3.98
528
3285
(3036481) Cortisol [Moles/volume] in Serum or Plasma
300
1559
2.04
26.75
2.4
2.1
nmol/l
347.1
385.6
2.55
281
1402
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
164
664
2.56
26.52
1.8
1.5
titre
114.0
273.0
—
10
37
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
101
315
3.29
26.29
1.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
77
202
3.89
25.98
1.9
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
528
3315
1.73
25.93
2.7
2.5
g/l
2.2
2.2
0.17
497
3056
(3008536) Aspergillus sp Ab [Presence] in Serum
30
31
9.77
25.89
2.2
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
79
213
3.79
25.65
1.9
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
505
3142
1.74
25.58
2.8
2.6
%
20.8
23.0
1.96
432
2679
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
184
805
2.38
25.16
2.8
2.2
ug/l
468.7
556.6
0.21
170
761
(3036489) Thrombin time
169
712
2.46
25.12
2.4
1.9
s
21.6
21.5
0.04
155
654
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
195
876
2.32
25.10
6.0
3.7
mmol/l
24.8
24.6
0.52
188
794
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
125
455
2.83
24.90
1.6
1.9
mg/l
10.6
13.2
1.40
118
411
(4306422)
77
210
3.74
24.60
1.3
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
21
13
16.27
24.56
1.6
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
31
36
8.70
24.53
2.8
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
137
528
2.68
24.47
1.8
1.2
iu/ml
10.6
12.6
—
6
7
(3007930) Methemoglobin/Hemoglobin.total in Blood
205
952
2.24
24.39
6.7
5.4
%
0.9
0.9
0.12
189
892
(3013707) Erythrocyte sedimentation rate by Westergren method
1764
14779
1.53
24.37
6.2
3.9
mm/h
17.5
13.5
15.17
1659
13425
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
58
130
4.53
24.07
1.4
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
580
3803
1.66
24.03
4.2
3.0
e6/l
1.3
1.1
0.56
323
2249
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
457
2812
1.75
23.94
3.5
4.3
u/l
257.1
250.8
0.24
435
2631
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
399
2379
1.79
23.26
5.4
3.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
910
6687
1.54
23.12
3.1
2.2
u/l
259.4
219.8
0.19
855
6244
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
436
2677
1.75
22.94
1.3
1.2
iu/ml
60.2
36.4
1.10
138
800
(3004119) Hemoglobin [Mass/volume] in Venous blood
267
1404
2.00
22.93
4.0
3.3
g/l
129.9
127.3
0.93
258
1365
(3024928) Oxygen saturation in Venous blood
126
481
2.70
22.93
2.7
3.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
95
311
3.13
22.85
6.2
2.5
u/ml
886.4
1375.6
—
5
30
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
138
558
2.55
22.38
2.6
2.4
g/l
3.9
3.6
1.05
131
529
(3018572) Chloride [Moles/volume] in Blood
129
507
2.62
22.17
7.4
7.4
mmol/l
103.8
105.6
3.64
114
450
(3039000) Anion gap in Blood
129
507
2.62
22.17
7.4
7.4
mmol/l
11.6
11.2
0.44
114
450
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
43
80
5.44
22.13
1.2
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
110
400
2.82
21.97
18.4
5.1
iu/ml
186.4
4630.3
0.59
25
57
(3003434) Protein [Mass/volume] in Pleural fluid
106
382
2.84
21.53
1.3
1.5
g/l
33.3
31.1
0.93
95
336
(3042733) HLA Ab [Presence] in Serum
35
55
6.43
21.37
4.4
5.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
121
470
2.65
21.29
1.7
1.4
g/l
0.2
0.2
0.01
114
442
(3026008) Bacteria identified in Urine by Culture
859
6323
1.52
21.27
3.8
3.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
89
298
3.05
20.62
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
186
896
2.15
20.18
3.2
3.0
u/ml
0.3
0.3
0.85
107
519
(3020630) Protein [Mass/volume] in Serum or Plasma
346
2059
1.78
20.15
2.4
2.7
g/l
65.3
66.0
0.90
320
1858
(3007164) IgA [Mass/volume] in Serum or Plasma
471
3057
1.65
19.94
1.7
1.5
g/l
2.9
2.6
0.77
313
1790
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
311
1805
1.81
19.68
4.3
4.1
mmol/l
1.2
1.2
0.60
270
1564
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
121
492
2.53
19.41
1.7
1.4
g/l
1.2
1.2
0.04
113
462
(3031040) Bacteria [#/volume] in Urine by Automated count
1626
13717
1.45
19.31
6.3
4.6
e6/l
683.5
1844.6
0.92
36
233
(3010375) cycloSPORINE [Mass/volume] in Blood
42
87
4.89
19.19
44.1
21.6
ug/l
166.1
114.2
3.47
33
67
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
785
5780
1.50
18.99
2.5
2.2
mg/l
3.4
3.0
3.85
670
4844
(3015736) pH of Urine
986
7597
1.46
18.96
4.0
3.4
—
5.8
—
0
12
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1199
9599
1.44
18.72
3.2
2.3
—
—
—
0
0
(4062490)
50
122
4.15
18.67
1.2
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
78
258
3.08
18.48
1.4
1.4
mmol/l
6.4
6.5
0.10
70
241
(3007853) Bacteria identified in Skin by Aerobe culture
376
2357
1.69
18.08
2.1
1.8
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
49
121
4.10
18.02
1.2
1.3
g/l
7.0
7.5
0.27
34
88
(3024139) IgG subclass 3 [Mass/volume] in Serum
49
121
4.10
18.02
1.2
1.3
g/l
0.4
0.4
0.12
35
88
(3028192) IgG subclass 2 [Mass/volume] in Serum
49
121
4.10
18.02
1.2
1.3
g/l
2.4
2.9
0.86
35
86
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
306
1814
1.77
17.98
2.0
1.7
%
1.8
1.6
4.30
258
1526
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
72
233
3.15
17.71
1.3
1.2
u/ml
2.7
4.8
1.20
35
108
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
74
247
3.05
17.28
1.3
1.2
u/ml
1.8
3.3
0.75
26
76
(3024980) IgG subclass 4 [Mass/volume] in Serum
67
212
3.21
17.12
1.5
1.6
g/l
0.8
0.9
0.38
52
167
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
67
214
3.18
16.86
1.2
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
32
59
5.47
16.65
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
32
59
5.47
16.65
1.0
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
63
196
3.27
16.55
1.2
1.3
u/l
20.0
12.9
0.57
58
181
(3037467) Urinalysis macro (dipstick) panel - Urine
1648
14135
1.41
16.55
5.6
4.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
44
108
4.12
16.33
2.8
2.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
60
183
3.33
16.28
1.4
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
60
183
3.33
16.28
1.4
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
60
183
3.33
16.28
1.4
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
139
650
2.20
16.26
4.7
3.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
81
295
2.80
16.20
1.4
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
134
622
2.21
15.97
1.7
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
209
1144
1.89
15.87
4.9
3.3
mmol/l
25.4
24.8
1.16
203
1109
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
991
7837
1.41
15.78
2.6
2.1
nmol/l
73.6
78.1
5.13
865
6829
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
72
251
2.92
15.61
1.2
1.4
u/l
440.2
316.5
0.89
67
237
(4268621)
53
154
3.49
15.51
2.5
2.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
19
5
38.26
15.38
1.3
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1192
9762
1.39
15.30
4.5
3.7
estimate
0.0
0.0
0.00
269
1814
(3027945) Reticulocytes/100 erythrocytes in Blood
437
2958
1.57
15.24
3.0
2.5
%
1.9
1.7
2.42
380
2584
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
56
171
3.32
15.18
1.1
1.1
u/ml
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
914
7164
1.41
15.18
3.9
3.4
mmol/l
2.3
2.3
0.27
805
6133
(3023183) Ammonium ion [Moles/volume] in Plasma
112
500
2.29
14.67
2.2
2.6
umol/l
33.8
35.9
0.33
92
418
(3023199) Leukocytes [#/volume] in Pleural fluid
85
337
2.57
14.44
1.4
1.5
e6/l
3534.5
1596.2
1.03
59
236
(40761536) Microorganisms panel - Urine sediment
280
1725
1.69
14.25
5.1
3.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
79
305
2.64
14.16
1.4
1.4
e6/l
37188.0
75522.6
0.63
47
184
(3001122) Ferritin [Mass/volume] in Serum or Plasma
993
7971
1.38
14.05
3.3
2.7
ug/l
186.6
175.1
0.43
904
7200
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
113
517
2.24
13.98
1.4
1.6
iu/ml
0.1
12.7
0.62
31
104
(3009261) Glucose [Presence] in Urine by Test strip
1198
9917
1.36
13.96
4.5
3.7
estimate
0.0
0.0
1.08
265
1757
(3004588) Protein electrophoresis panel - Serum or Plasma
278
1727
1.68
13.70
2.3
2.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
70
259
2.75
13.64
6.2
8.5
mmol/l
7.5
7.5
0.04
65
210
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
110
504
2.23
13.57
1.8
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
70
261
2.73
13.44
1.4
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
29
60
4.87
13.31
1.1
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1179
9788
1.35
13.26
6.2
4.9
estimate
0.0
0.0
0.00
269
1847
(40757373) Influenza virus identified in Isolate
26
49
5.35
13.24
2.7
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
49
151
3.28
13.13
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
553
4092
1.44
12.26
3.3
3.2
mmol/l
2.5
2.5
7.50
488
3585
(3009871) Measles virus Ab [Titer] in Serum
23
42
5.51
12.11
1.2
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
129
658
2.01
12.07
2.5
2.5
g/l
0.0
0.0
0.00
119
603
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
359
2448
1.54
11.95
3.1
4.1
ug/l
14.6
26.2
0.64
316
2045
(3043409) Potassium [Moles/volume] in Arterial blood
134
697
1.97
11.87
6.5
3.9
mmol/l
4.0
3.9
1.52
116
641
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
135
708
1.95
11.68
2.5
2.4
g/l
0.1
0.0
0.34
125
641
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
39
1144
0.33
11.65
1.7
1.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
129
668
1.98
11.58
2.5
2.4
g/l
0.0
0.0
0.00
119
604
(3034426) Prothrombin time (PT)
24
48
5.03
11.46
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
48
159
3.05
11.46
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
36
101
3.60
11.17
1.2
1.1
u/ml
2.4
0.9
0.98
15
32
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
49
167
2.97
11.15
1.4
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
151
840
1.84
10.93
2.6
3.7
mg/l
38.8
51.1
0.78
114
691
(3037756) Immunofixation for Serum or Plasma
110
550
2.04
10.90
1.4
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
41
128
3.24
10.81
5.0
3.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
147
817
1.84
10.68
2.7
3.7
ratio
6.0
2.1
—
7
57
(3034860) Kappa light chains.free [Mass/volume] in Serum
150
840
1.83
10.64
2.7
3.7
mg/l
99.2
63.9
0.51
110
686
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
70
294
2.42
10.61
1.2
1.2
u/ml
383.3
271.2
1.22
48
172
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
30
77
3.93
10.56
2.9
1.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
30
77
3.93
10.56
2.9
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
81
368
2.24
10.27
1.4
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
120
635
1.93
10.15
2.3
3.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
38
118
3.25
10.12
1.7
2.4
%
16.8
16.6
0.02
17
43
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
38
118
3.25
10.12
1.8
2.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1384
12047
1.30
10.11
4.0
3.1
u/l
57.1
56.7
0.05
1275
11004
(40768797) Stomach Pathology biopsy report
378
2696
1.47
10.05
1.5
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
604
4679
1.37
10.04
3.8
3.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
31
85
3.68
9.97
1.1
1.1
u/ml
1.8
5.3
1.09
12
35
(3011648) Oxygen content in Venous blood
47
167
2.85
9.96
1.5
2.7
%
10.2
11.1
0.59
47
167
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
144
817
1.80
9.81
2.7
2.6
g/l
1.6
1.1
0.34
127
689
(3023520) Reticulocytes [#/volume] in Blood
324
2254
1.49
9.75
3.0
2.6
e9/l
75.0
66.4
3.51
223
1723
(3008401) Mugwort IgE Ab [Units/volume] in Serum
31
87
3.59
9.65
1.1
1.1
u/ml
2.2
1.0
0.53
11
30
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
127
697
1.86
9.63
1.4
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
72
321
2.28
9.57
1.4
1.4
u/ml
109.5
123.7
0.40
15
65
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
910
1.74
9.41
2.5
2.5
g/l
10.8
10.2
0.74
135
759
(3003181) Sodium [Moles/volume] in Urine
79
370
2.17
9.33
1.4
1.3
mmol/l
63.3
64.0
0.05
63
296
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
133
750
1.81
9.26
2.5
2.3
g/l
35.1
37.4
4.18
120
634
(3002385) Erythrocyte distribution width [Ratio]
1752
15817
1.29
9.24
37.1
19.4
%
14.5
13.8
55.82
1731
15393
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
32
95
3.40
9.17
1.8
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
162
971
1.71
9.14
2.4
2.5
g/l
4.4
3.8
0.79
123
684
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
162
971
1.71
9.14
2.4
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
162
972
1.71
9.10
2.4
2.5
g/l
7.6
7.3
1.13
125
711
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
152
896
1.74
9.10
2.5
2.5
g/l
3.3
3.1
1.89
126
698
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
28
77
3.66
8.99
1.1
1.2
ratio
1.0
1.1
—
5
26
(3021879) Hepatitis B virus core Ab [Presence] in Serum
173
1062
1.67
8.93
1.4
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
35
112
3.15
8.91
1.9
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
53
214
2.51
8.80
4.7
3.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
31
93
3.36
8.75
1.4
2.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
74
347
2.16
8.74
1.4
1.2
u/ml
3.3
12.2
—
5
22
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
70
321
2.21
8.73
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
106
567
1.90
8.73
1.5
1.4
ug/g
232.0
264.9
0.84
63
336
(3019309) Folate [Moles/volume] in Red Blood Cells
607
4799
1.34
8.69
1.9
1.8
nmol/l
1181.7
1164.1
0.16
454
3539
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
48
186
2.61
8.67
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
354
2562
1.44
8.67
1.2
1.2
u/ml
24.8
12.4
1.39
113
908
(3048929) Epstein Barr virus Ab [Presence] in Serum
84
416
2.05
8.62
1.2
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
65
293
2.25
8.46
1.4
1.2
u/ml
42.9
49.6
0.16
11
27
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
259
1774
1.51
8.39
1.5
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
62
275
2.28
8.39
1.3
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
32
101
3.19
8.35
5.3
2.4
mmol/l
8.0
9.5
1.48
21
79
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1798
19467
0.78
8.23
4.5
4.7
mmol/l
4.2
4.4
12.60
1615
17677
(3017143) Hepatitis C virus Ab [Presence] in Serum
247
1686
1.51
8.14
1.5
1.5
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
11
14
7.88
7.99
1.0
1.1
%
100.7
106.0
0.26
11
14
(3011412) CD3 cells [#/volume] in Blood
44
171
2.60
7.93
1.8
2.2
e9/l
1.0
1.0
0.10
31
91
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1780
19262
0.79
7.88
4.4
4.7
mmol/l
1.4
1.4
4.51
1582
17340
(3004809) Band form neutrophils/100 leukocytes in Blood
79
397
2.02
7.82
3.4
4.0
%
1.1
1.4
0.43
68
291
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
192
1256
1.57
7.68
1.5
1.7
g/l
1.7
1.5
2.73
164
1060
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
49
204
2.43
7.67
1.7
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
535
6667
0.76
7.65
2.6
3.2
ug/l
0.7
0.8
1.28
369
4735
(44813793)
23
62
3.73
7.62
1.1
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
89
472
1.91
7.56
1.2
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
81
419
1.96
7.41
1.5
1.2
u/ml
4.2
9.0
0.60
12
56
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
17
37
4.62
7.40
1.1
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
80
415
1.95
7.27
1.5
1.2
u/ml
5.9
3.9
—
10
39
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
37
138
2.70
7.25
1.3
1.1
titre
136.3
138.6
—
8
21
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
22
60
3.69
7.18
1.2
1.1
u/ml
—
17.1
—
0
7
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
17
38
4.49
7.17
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
27
742
0.36
7.15
1.4
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
41
165
2.51
6.92
2.2
2.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
48
208
2.33
6.91
1.5
1.7
—
1342.2
—
0
9
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
48
3.98
6.89
1.1
1.4
%
67.9
74.6
0.28
11
28
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
40
160
2.52
6.84
1.1
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
23
67
3.45
6.83
3.0
2.3
u/ml
404.0
43410.3
—
7
11
(3044640) Blood type and Crossmatch panel - Blood
808
6816
1.26
6.83
3.1
2.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
25
77
3.27
6.82
1.2
1.0
u/ml
4.4
3.1
—
6
14
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1866
19974
0.80
6.79
5.1
5.3
mmol/l
2.4
2.6
14.44
1675
18020
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
50
223
2.26
6.74
1.7
1.3
nmol/l
0.2
0.4
—
9
18
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
229
1602
1.47
6.70
3.9
3.9
ng/l
91.5
98.4
0.64
189
1371
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
14
7.16
6.70
1.0
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
92
514
1.82
6.69
3.1
2.9
nmol/l
0.8
0.8
0.35
82
378
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1731
18664
0.81
6.64
3.9
4.2
mmol/l
1.3
1.3
2.46
1523
16668
(4035726)
258
1856
1.43
6.51
1.4
1.3
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
14
29
4.85
6.45
1.1
1.2
%
83.8
80.8
—
5
10
(1761868) Lipid panel - Serum or Plasma
491
6064
0.77
6.38
3.3
3.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
35
136
2.59
6.37
2.2
2.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
62
309
2.03
6.34
6.4
6.9
mg/l
12.2
12.4
0.07
55
288
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
14
30
4.68
6.21
1.1
1.1
%
73.2
79.4
—
5
10
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
40
168
2.40
6.20
1.7
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
44
193
2.30
6.20
1.5
1.3
nmol/l
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
656
5455
1.26
6.17
1.8
1.6
nmol/l
17.5
20.1
5.16
568
4593
(3004451) EKG impression Narrative
32
121
2.66
6.15
1.4
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1596
14598
1.22
6.03
5.6
4.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
30
111
2.72
6.01
1.4
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
30
111
2.72
6.01
1.4
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
30
111
2.72
6.01
1.4
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
30
111
2.72
6.01
1.4
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
79
436
1.84
6.01
2.0
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
57
284
2.03
5.86
1.5
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
620
5171
1.26
5.63
4.6
3.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2104
19857
1.24
5.62
33.2
15.7
mg/l
29.7
27.8
1.62
1946
15971
(3025941) Bacteria identified in Stool by Culture
143
942
1.55
5.62
1.3
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
32
128
2.52
5.53
4.5
3.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
12
25
4.82
5.49
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
42
192
2.21
5.41
1.4
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1049
9284
1.21
5.34
2.2
2.1
pmol/l
87.6
92.6
3.60
617
4975
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
17
48
3.56
5.32
1.1
1.1
%
69.5
80.0
—
10
27
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
22
74
2.99
5.25
1.2
1.3
ug/l
65.9
160.0
0.45
15
27
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
69
3.06
5.21
1.2
1.0
u/ml
2.2
1.7
—
10
24
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
29
114
2.56
5.21
1.8
2.0
e9/l
0.2
0.2
0.39
24
100
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
205
2796
0.71
5.17
4.1
4.8
%
32.8
32.8
0.01
144
1805
(3047007) Chlamydophila sp Ab [Presence] in Serum
37
164
2.27
5.14
1.1
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
287
2188
1.35
5.13
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
49
930
0.52
5.09
1.3
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
25
93
2.70
5.00
3.3
6.7
mg/l
76.8
63.6
0.44
18
67
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
813
9279
0.82
4.97
4.1
4.6
%
22.1
22.2
0.10
374
4905
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
69
389
1.79
4.96
1.4
1.2
u/l
38.3
49.9
0.45
62
337
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
38
174
2.20
4.90
1.1
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
91
558
1.65
4.86
2.2
3.2
mg/l
1.9
1.7
1.65
84
493
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
74
429
1.74
4.85
1.3
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
52
271
1.94
4.78
1.1
1.2
miu/ml
167.2
196.2
—
8
92
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
29
120
2.43
4.71
1.8
2.0
e6/l
448.4
517.2
0.30
23
100
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
217
2886
0.73
4.68
10.9
7.6
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
23
85
2.72
4.67
4.7
4.4
%
56.7
55.2
0.10
23
80
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
46
234
1.98
4.55
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
60
335
1.81
4.49
1.6
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
31
136
2.29
4.45
2.2
2.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
19
65
2.94
4.44
1.3
1.0
u/ml
1.2
2.7
—
8
21
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
61
345
1.79
4.38
1.3
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
35
3.73
4.36
1.8
2.1
e6/l
100.0
157.8
—
7
9
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1856
19598
0.84
4.35
4.8
4.9
mmol/l
6.1
6.1
0.56
1651
17418
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
128
873
1.49
4.34
3.2
3.2
u/ml
877.8
4877.0
0.66
111
751
(21494814) CD8 cells/100 lymphocytes in Specimen
19
66
2.89
4.33
1.6
2.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
15
45
3.35
4.32
3.8
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
288
2254
1.31
4.31
2.9
2.3
ug/l
9.9
8.0
0.75
249
1934
(3013293) Extractable nuclear Ab [Presence] in Serum
10
22
4.56
4.30
1.6
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
79
2.67
4.15
1.4
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
79
2.67
4.15
1.4
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
30
134
2.25
4.15
1.3
1.4
promille
1.4
1.0
0.88
23
105
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
23
91
2.54
4.13
1.3
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
57
2.99
4.12
1.8
2.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
80
2.64
4.06
1.5
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1077
9737
1.17
3.98
5.0
4.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
663
5754
1.20
3.95
4.5
2.9
umol/l
3175.5
6148.0
1.41
580
4877
(3021788) Differential panel - Synovial fluid
63
374
1.70
3.87
1.5
1.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
19
71
2.69
3.82
1.7
2.4
%
6.9
9.2
0.44
19
66
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
159
2.09
3.82
1.4
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
610
5269
1.20
3.81
3.0
2.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
15
6.02
3.81
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
629
5453
1.20
3.78
4.9
4.0
estimate
0.0
0.0
0.26
255
1691
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
44
3.19
3.77
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
421
3514
1.23
3.71
28.5
29.4
inr
1.4
1.5
0.59
45
511
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
129
914
1.43
3.65
2.9
3.4
pmol/l
4.2
4.4
1.22
107
782
(3016879) Cocaine [Presence] in Urine
38
198
1.93
3.58
1.9
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1793
18872
0.86
3.53
6.2
6.3
mmol/mol
41.3
40.7
1.64
1623
17119
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
243
1912
1.30
3.53
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
846
7560
1.17
3.53
4.9
4.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
10
26
3.86
3.52
1.1
1.2
umol/24h
2.0
1.9
—
10
26
(3046861) Legionella sp Ag [Presence] in Urine
8
13
6.17
3.50
1.4
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
6
10.02
3.49
1.7
1.7
—
—
—
0
0
(4198724)
11
31
3.56
3.48
1.1
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
14
47
2.99
3.41
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
14
47
2.99
3.41
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
14
47
2.99
3.41
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
14
47
2.99
3.41
1.1
1.0
—
—
—
0
0
(4133840)
13
42
3.10
3.37
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
403
3394
1.22
3.26
1.2
1.2
u/ml
0.9
1.9
3.67
85
873
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
135
987
1.39
3.23
2.3
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
38
206
1.86
3.21
1.6
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
87
587
1.50
3.20
1.6
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
228
1808
1.28
3.14
2.2
2.2
ug/g
153.3
164.9
0.19
183
1413
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1061
11535
0.87
3.14
4.5
5.4
ug/l
3.1
4.4
1.28
898
10227
(3003327) Ova and parasites identified in Stool by Light microscopy
70
453
1.56
3.12
1.8
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
78
518
1.52
3.10
1.7
1.6
e6/l
15156.6
14149.9
0.07
53
368
(3027008) Opiates [Presence] in Urine
39
216
1.82
3.09
1.9
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
39
217
1.81
3.05
1.9
1.6
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
25
119
2.11
3.04
1.8
2.2
e9/l
0.1
0.2
0.68
25
113
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
26
126
2.07
3.02
1.8
2.8
%
45.1
34.7
—
10
42
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
35
189
1.86
3.01
1.5
1.3
%
24.8
22.6
0.15
26
118
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
22
100
2.21
2.99
1.2
1.4
u/l
5.7
7.2
0.72
17
85
(3027944) Amphetamines [Presence] in Urine
38
212
1.80
2.96
1.9
1.5
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
31
162
1.92
2.94
2.1
1.5
u/ml
26.7
22.2
—
7
34
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
20
88
2.28
2.93
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
39
220
1.78
2.93
1.2
1.3
pmol/l
254.6
255.1
0.00
28
166
(3001729) Color of Synovial fluid
9
23
3.92
2.77
1.3
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1505
14177
1.13
2.76
3.7
3.6
pmol/l
15.2
14.9
2.16
1345
12519
(40768441) Liver Pathology biopsy report
26
131
1.99
2.75
1.2
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
12
42
2.86
2.75
1.6
1.5
ug/l
0.2
0.4
—
5
25
(40768800) Prostate Pathology biopsy report
46
738
0.62
2.74
1.2
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
37
211
1.76
2.70
1.2
1.4
mosm/kgh2o
277.3
279.1
0.16
31
158
(3034770) Mitochondria Ab [Titer] in Serum
71
480
1.49
2.64
1.3
1.2
titre
602.0
1373.6
—
5
14
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
49
2.66
2.62
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
41
244
1.69
2.60
4.0
4.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
37
215
1.73
2.55
1.9
1.6
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
122
920
1.34
2.48
2.1
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
82
579
1.43
2.47
1.5
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
55
358
1.55
2.46
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
14
57
2.46
2.44
1.2
1.1
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
5
8
6.26
2.37
1.2
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
87
627
1.40
2.35
1.3
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
112
1471
0.75
2.32
1.5
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
39
238
1.65
2.29
1.1
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
22
113
1.95
2.25
1.0
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
22
113
1.95
2.25
1.0
1.5
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
19
93
2.05
2.21
1.1
1.2
u/l
154.5
444.9
1.45
19
88
(3009214) Lutropin [Units/volume] in Serum or Plasma
49
320
1.54
2.19
1.2
1.3
u/l
7.7
9.4
0.64
33
255
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
24
3.34
2.18
2.8
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
28
158
1.78
2.17
1.3
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
27
463
0.58
2.16
1.6
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
81
2.11
2.12
1.3
1.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
15
68
2.21
2.11
2.0
1.7
umol/l
106.4
67.8
—
9
39
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
55
0.00
2.06
0.0
3.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
35
214
1.64
2.06
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
152
1226
1.25
1.92
1.2
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
14
65
2.16
1.88
4.1
8.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
46
2.40
1.85
1.9
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
17
3.53
1.83
1.3
1.8
umol/l
15.3
16.9
—
6
17
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
538
4863
1.13
1.81
1.7
1.7
pmol/l
441.0
26539366.5
3.49
408
3915
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
205
1723
1.20
1.77
3.6
2.7
ml/min/173m2
63.1
61.9
0.14
85
729
(3010144) Erythrocytes [#/volume] in Synovial fluid
33
208
1.59
1.76
1.3
1.3
e6/l
21300.9
140170.9
1.54
23
153
(3036670) Protein [Mass/volume] in Synovial fluid
14
67
2.09
1.76
1.1
1.2
g/l
36.0
39.3
—
9
31
(3034891) Synovial lining cells/100 cells in Synovial fluid
17
88
1.94
1.74
1.2
1.4
%
0.5
3.9
—
6
22
(3000012) Reticulocyte production index
25
147
1.71
1.73
1.4
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
90
690
1.31
1.72
1.3
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
24
2.92
1.72
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
54
381
1.43
1.72
1.4
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
47
323
1.46
1.71
3.7
2.4
—
—
—
0
0
(4146454)
14
269
0.52
1.71
2.2
2.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
45
308
1.47
1.68
1.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
34
219
1.56
1.67
3.0
2.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
71
529
1.35
1.65
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1798
17362
1.10
1.65
33.8
17.1
%
38.8
39.0
0.20
1143
11012
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
49
2.25
1.63
1.6
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
62
454
1.37
1.61
1.3
1.5
—
—
—
0
0
(44806071)
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
30
462
0.65
1.61
1.8
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
39
262
1.50
1.60
2.2
2.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
43
2.33
1.60
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
20
3.00
1.58
1.5
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
70
525
1.34
1.58
1.3
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
137
1.68
1.55
2.0
1.9
e6/l
747.8
625.6
—
9
61
(3001686) Cold agglutinin [Titer] in Serum or Plasma
10
44
2.28
1.53
1.3
1.3
—
127.0
—
0
9
(3052592) Norovirus Ag [Presence] in Stool
10
44
2.28
1.53
1.0
1.5
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
6
21
2.86
1.50
1.0
1.3
mmol/l
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
19
108
1.76
1.50
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
19
108
1.76
1.50
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
19
108
1.76
1.50
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
69
521
1.33
1.50
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
46
325
1.42
1.49
2.5
3.7
—
—
—
0
0
(1002224) Polysomnography panel
70
532
1.32
1.46
1.1
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
30
195
1.54
1.45
1.2
1.1
u/l
56.9
61.7
0.13
21
133
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
9
38
2.37
1.45
1.0
1.3
%
118.3
108.4
—
9
32
(3000963) Hemoglobin [Mass/volume] in Blood
2137
21852
0.90
1.45
43.0
23.5
g/l
133.0
134.6
4.48
2101
21390
(3028717) Thiamine [Mass/volume] in Blood
5
16
3.13
1.44
1.0
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
16
3.13
1.44
1.2
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
39
2.31
1.43
1.8
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
19
110
1.73
1.42
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
19
110
1.73
1.42
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
19
110
1.73
1.42
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2137
21847
0.91
1.42
42.5
23.4
e12/l
4.4
4.4
1.04
2066
21041
(3024731) MCV [Entitic volume]
2137
21846
0.91
1.42
42.4
23.3
fl
92.4
91.7
7.21
2102
21386
(3035941) MCH [Entitic mass]
2137
21845
0.91
1.41
42.4
23.3
pg
30.5
30.5
0.87
2102
21384
(3010813) Leukocytes [#/volume] in Blood
2138
21854
0.91
1.41
42.6
23.4
e9/l
8.2
6.8
58.16
2069
21049
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
314
0.60
1.41
1.5
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2137
21842
0.91
1.40
42.6
23.4
e9/l
258.1
235.1
33.59
2077
21117
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
111
1.72
1.39
1.3
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
119
1.69
1.37
1.7
2.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
63
477
1.33
1.37
1.3
1.2
titre
71.0
86.5
—
10
34
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
17
2.94
1.36
1.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
17
2.94
1.36
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
54
2.04
1.32
2.1
1.3
ug/l
11.3
9.9
0.29
11
54
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
15
83
1.81
1.31
2.1
2.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
51
377
1.36
1.30
1.9
1.8
iu/l
3.8
5.2
0.48
14
117
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
34
2.36
1.29
1.1
1.3
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
55
2.00
1.27
1.3
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
55
2.00
1.27
1.1
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
109
896
1.23
1.25
1.2
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
35
244
1.44
1.25
1.5
1.5
%
59.1
64.7
0.34
25
154
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
25
2.40
1.24
1.2
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
11
56
1.97
1.22
4.0
8.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
26
2.31
1.18
1.5
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
55
419
1.32
1.18
1.7
1.4
e6/l
4097.5
637.8
0.54
42
344
(3037121) Protein [Mass/volume] in Urine
99
812
1.23
1.18
2.7
3.0
g/l
0.3
0.3
0.41
45
340
(3016650) Hepatitis A virus Ab [Presence] in Serum
38
273
1.40
1.17
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
55
420
1.32
1.16
1.6
1.4
e6/l
4.6
28.3
0.99
41
332
(3045414) Leukocytes [Presence] in Urine
75
930
0.80
1.12
2.3
1.9
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
31
2.26
1.10
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
66
1.82
1.09
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
185
1.46
1.08
1.4
1.7
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
32
2.19
1.08
1.4
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
80
650
1.24
1.06
1.4
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
67
1.79
1.04
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
24
348
0.69
1.04
1.3
1.5
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
22
2.27
1.03
1.0
1.1
u/l
9.8
13.1
—
5
22
(3035933) Granulocytes/100 leukocytes in Blood
7
34
2.06
1.03
6.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
87
718
1.22
1.01
1.3
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
34
248
1.38
0.99
2.8
3.9
%
58.8
55.4
0.35
22
148
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
259
0.65
0.96
1.2
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
45
346
1.31
0.95
1.2
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
19
125
1.52
0.94
1.5
1.6
u/field
2.9
1.8
0.30
13
82
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
32
234
1.37
0.93
1.5
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
109
1.56
0.93
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1839
18799
0.94
0.93
29.7
15.3
ml/min/173m2
75.4
74.2
1.48
1583
15556
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
21
142
1.48
0.92
1.1
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
13
78
1.67
0.91
2.8
1.8
u/l
39.9
55.6
0.26
13
73
(3023410) Appearance of Cerebral spinal fluid
25
176
1.42
0.90
2.3
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
102
1.57
0.90
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
102
1.57
0.90
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
37
280
1.33
0.88
1.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
56
1.79
0.87
1.8
2.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
8
43
1.86
0.87
3.0
2.1
nmol/l
123.4
139.2
—
8
37
(3014891) Appearance of Pleural fluid
8
44
1.82
0.85
1.1
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
44
1.82
0.85
1.1
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
30
221
1.36
0.85
1.1
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
14
88
1.59
0.84
1.3
2.4
e6/l
244.4
8246.0
—
9
73
(40768795) Lymph node Pathology biopsy report
25
179
1.40
0.84
1.2
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
46
1.74
0.82
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
15
97
1.55
0.81
2.1
1.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
36
276
1.31
0.80
1.3
1.3
iu/l
33.8
31.6
0.14
30
231
(4094501)
46
575
0.80
0.80
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
58
1.73
0.79
1.0
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
26
190
1.37
0.79
1.6
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
32
242
1.33
0.78
1.1
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
26
0.00
0.78
0.0
2.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
74
1.62
0.78
1.8
2.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
39
305
1.28
0.76
3.0
2.1
mg/l
30.7
23.3
0.37
11
57
(3005570) Glucose [Moles/volume] in Urine
29
218
1.33
0.75
2.1
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
466
4394
1.07
0.70
4.6
4.1
kg/l
1.0
1.0
0.38
74
689
(3045142) Bone marrow Pathology biopsy report
36
284
1.27
0.68
1.1
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
19
136
1.40
0.66
2.1
2.0
min
520.4
496.0
—
7
96
(4212803)
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
22
294
0.75
0.66
1.3
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
44
1.59
0.65
1.7
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
44
1.59
0.65
4.9
8.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
1.8
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
53
442
1.20
0.62
1.6
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1811
17790
1.05
0.62
4.7
4.3
mu/l
2.0
2.1
1.03
1618
15794
(3029075) Extractable nuclear Ab panel - Serum
8
49
1.63
0.62
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
83
721
1.16
0.62
1.4
1.6
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
77
668
1.16
0.59
5.9
3.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
157
1.34
0.59
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
52
616
0.84
0.58
2.1
2.3
ug/min
83.5
86.8
0.03
27
365
(46235168) Fasting glucose [Moles/volume] in Blood
0
23
0.00
0.58
0.0
1.5
—
7.2
—
0
12
(3035320) C reactive protein [Mass/volume] in Body fluid
19
140
1.36
0.58
5.5
2.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
15
106
1.42
0.57
2.2
3.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
62
1.45
0.53
1.8
1.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2094
21187
0.95
0.52
34.9
19.0
umol/l
87.0
85.8
0.47
2094
21178
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
99
0.61
0.52
1.3
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
64
1.41
0.51
1.1
2.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
19
144
1.32
0.50
2.8
2.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
17
127
1.34
0.49
1.3
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
35
289
1.21
0.49
2.5
2.1
u/ml
10.2
175.2
0.63
30
281
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
35
289
1.21
0.49
1.0
1.1
iu/ml
17.1
67.9
—
8
51
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
46
1.52
0.48
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
24
191
1.26
0.46
1.9
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
25
201
1.25
0.45
2.0
2.2
ml
480.3
632.2
—
9
124
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
69
1.45
0.44
1.7
1.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
51
1.37
0.44
1.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
140
1.29
0.42
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
140
1293
1.09
0.41
2.9
3.4
e9/l
5.3
4.2
3.47
102
911
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
50.1
—
0
17
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
34
1.47
0.40
1.6
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
22
271
0.81
0.40
1.5
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(4211845)
15
115
1.31
0.38
2.2
3.6
—
—
—
0
0
(4027681)
11
80
1.38
0.38
1.3
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
159
0.75
0.38
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
269
0.82
0.38
1.5
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
112
0.71
0.37
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
112
0.71
0.37
1.4
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
72
1.39
0.36
1.5
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2097
21156
0.96
0.36
15.3
10.8
u/l
25.2
26.4
1.12
2039
20174
(3006653) Thiamine [Moles/volume] in Blood
13
99
1.31
0.35
1.1
1.2
nmol/l
167.1
137.3
0.79
13
99
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
58
519
1.12
0.34
2.8
3.3
u/ml
307.3
1168.6
0.86
51
488
(3036603) Volume of Urine
16
127
1.26
0.33
1.8
1.7
—
1790.0
—
0
38
(3051387) C reactive protein [Mass/volume] in Capillary blood
56
501
1.12
0.33
6.7
3.4
mg/l
30.3
31.1
0.06
42
322
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
23
274
0.84
0.32
1.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
180
1903
0.94
0.32
4.0
3.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
53
1.32
0.30
1.1
1.1
—
—
—
0
0
(4024509)
18
218
0.82
0.30
1.7
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
274
2857
0.95
0.30
1.3
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
8
110
0.73
0.28
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
112
1.25
0.28
1.5
1.5
u/l
3.3
9.7
—
8
58
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
94
1.28
0.28
1.6
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
94
1.28
0.28
1.6
1.1
—
—
—
0
0
(3019225) pH of Specimen
222
2320
0.95
0.27
4.3
4.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
66
718
0.92
0.26
1.1
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
71
0.70
0.26
1.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
73
0.68
0.26
1.4
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
33
291
1.14
0.26
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
82
0.73
0.24
1.2
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
6
84
0.71
0.24
1.0
1.1
—
259.5
—
0
25
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
152
1.19
0.23
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
29
256
1.13
0.23
1.5
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
91
854
1.07
0.22
1.3
1.2
iu/ml
190.1
133.8
0.32
27
305
(44806420)
7
91
0.77
0.22
2.7
2.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
42
1.19
0.21
1.0
1.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
187
1796
1.04
0.21
1.6
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
98
1.23
0.21
4.7
6.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
13
0.00
0.21
0.0
1.0
—
77.6
—
0
8
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
13
0.00
0.21
0.0
2.6
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
164
1.16
0.20
1.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
48
1.25
0.20
1.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
126
1201
1.05
0.20
2.5
2.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
53
1.13
0.18
1.2
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
128
1.17
0.18
2.1
1.8
u/l
4621.2
2450.7
—
8
42
(3005988) Vibrio sp identified in Specimen by Organism specific culture
24
269
0.89
0.18
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
24
269
0.89
0.18
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
24
269
0.89
0.18
1.4
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
11
91
1.21
0.17
1.3
1.1
u/l
1.0
1.2
—
6
47
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
66
0.76
0.17
1.0
1.0
miu/ml
2272.6
1677.4
—
5
66
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
129
1.16
0.17
1.3
1.2
mmol/l
11.6
12.3
—
6
40
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
68
0.73
0.17
1.2
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
69
1.16
0.16
1.5
2.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
27
244
1.11
0.16
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
76
801
0.95
0.16
1.2
1.3
—
—
—
0
0
(4034850)
61
647
0.94
0.15
12.9
11.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
80
0.75
0.15
1.0
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
80
0.75
0.15
1.0
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1607
15968
1.01
0.14
40.3
20.9
g/l
329.4
332.5
28.65
1592
15786
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
98
0.82
0.13
1.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
128
0.86
0.13
1.8
2.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
151
1.13
0.13
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
115
1190
0.96
0.12
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
181
1854
0.97
0.11
2.3
2.1
nmol/l
13.6
12.1
0.92
146
1609
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
134
1.12
0.10
1.9
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
525
5190
1.01
0.10
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
126
1226
1.03
0.10
2.8
2.8
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
15
166
0.90
0.09
1.6
2.0
ug/l
16.5
3.9
—
10
143
(3002523) Influenza virus A Ag [Presence] in Specimen
18
164
1.10
0.09
1.0
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
10
114
0.88
0.09
1.3
1.9
nmol/l
15.9
15.7
—
10
104
(3013512) EKG study
685
6788
1.01
0.09
5.7
4.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
55
1.09
0.09
1.3
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
67
1.04
0.08
1.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
67
1.04
0.08
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
73
0.82
0.07
3.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
108
1.11
0.07
1.4
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
723
7278
0.99
0.07
3.7
4.0
mg/mmol
13.3
9.4
1.03
492
4729
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
88
1.02
0.07
1.3
1.2
iu/ml
112.3
219.1
—
9
88
(3022621) pH of Urine by Test strip
143
1455
0.98
0.06
3.0
3.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
66
678
0.97
0.05
1.1
1.1
—
177.2
—
0
16
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
100
1.10
0.05
2.5
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
40
414
0.97
0.05
1.2
1.4
nmol/l
0.8
0.8
0.25
33
340
(3012516) Albumin [Mass/volume] in Urine
691
6874
1.01
0.05
3.0
3.3
mg/l
488.6
274.3
0.64
476
4473
(40768804) Tissue Pathology biopsy report
805
8015
1.01
0.04
2.3
2.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2113
21097
1.01
0.04
36.4
18.8
mmol/l
138.9
139.7
30.71
2070
20478
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
521
5237
0.99
0.04
1.7
1.6
mmol/l
1.4
1.3
1.32
440
4330
(3009508) Creatinine [Moles/volume] in Urine
703
7004
1.00
0.03
2.9
3.2
mmol/l
7.5
7.7
0.49
600
5767
(3000330) Specific gravity of Urine by Test strip
122
1206
1.01
0.03
5.4
3.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
11
118
0.93
0.02
1.0
1.1
—
7.5
—
0
29
(3047189) Immunofixation for 24 hour Urine
14
132
1.06
0.02
1.6
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
38
389
0.98
0.02
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
13
136
0.96
0.00
5.6
15.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2115
21142
1.00
0.00
36.4
19.0
mmol/l
4.0
4.0
1.39
2067
20491
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
45
445
1.01
0.00
1.4
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
21
211
1.00
0.00
2.1
3.3
mg/l
175.8
30.3
0.73
13
180
(4281824)
16
157
1.02
0.00
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
49
495
0.99
0.00
2.8
2.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
106
1.04
0.00
1.4
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2040
20397
1.00
0.00
26.5
15.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
98
1.02
0.00
1.1
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
102
0.98
0.00
1.2
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
218
1.01
0.00
1.9
1.9
u/field
1.5
2.2
—
10
72
(3029396) Erythrocyte agglutination [Presence] in Blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
8
0.00
0.00
0.0
1.1
—
7.9
—
0
8
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
7.9
—
0
6
(3017400) Magnesium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
2.3
—
0
6
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
6.7
—
59.2
—
0
6
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
1.1
—
0
8
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1.1
—
0
5
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
588.0
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.4
—
3.3
—
0
5
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
5
0.00
0.00
0.0
2.0
—
890.6
—
0
5
(3020650) Glucose [Presence] in Urine
5
51
0.98
0.00
1.2
1.6
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
9
0.00
0.00
0.0
2.0
—
1.6
—
0
9
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
55
0.91
0.00
1.0
2.2
ug/l
3.6
1.1
—
5
49
(3018291) Platelet Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
1.4
—
172.8
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
61
0.98
0.00
1.7
1.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_EMPHYSEMA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_EMPHYSEMA | 3.684 [3.14, 4.33] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 1167 out of 3260 females with J10_EMPHYSEMA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_EMPHYSEMA | 3.237 [2.81, 3.72] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 3606 out of 7590 males with J10_EMPHYSEMA died.
Mortality risk
Mortality risk for people of age
years, who have J10_EMPHYSEMA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.307% | 0.643% |
| 5 | 1.856% | 3.69% |
| 10 | 4.444% | 8.79% |
| 15 | 8.028% | 16.011% |
| 20 | 13.584% | 25.898% |
Relationships between endpoints
↥Index endpoint: J10_EMPHYSEMA – Emphysema
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data